These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1365437

  • 1. Effects of chronic levodopa on D1 and D2 receptor-mediated striatal output.
    Engber TM, Susel Z, Weick BG, Walters JR, Chase TN.
    Neurochem Int; 1992 Mar; 20 Suppl():255S-260S. PubMed ID: 1365437
    [No Abstract] [Full Text] [Related]

  • 2. [Different effects on dopamine receptors D1 and D2 following long-term usage of L-dopa].
    Wei D.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Apr; 24(2):104-7, 125. PubMed ID: 1830547
    [Abstract] [Full Text] [Related]

  • 3. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN.
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [Abstract] [Full Text] [Related]

  • 4. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
    Waszczak BL, Martin LP, Finlay HE, Zahr N, Stellar JR.
    J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
    [Abstract] [Full Text] [Related]

  • 10. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN, Bergstrom DA, Mastropietro CW, Twery MJ, Walters JR.
    Neuroscience; 1999 Mar; 91(3):935-46. PubMed ID: 10391472
    [Abstract] [Full Text] [Related]

  • 11. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.
    Robertson GS, Vincent SR, Fibiger HC.
    Neuroscience; 1992 Jul; 49(2):285-96. PubMed ID: 1359451
    [Abstract] [Full Text] [Related]

  • 12. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ, Marshall JF.
    Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899
    [Abstract] [Full Text] [Related]

  • 13. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
    Abercrombie ED, DeBoer P, Heeringa MJ.
    Adv Pharmacol; 1998 Jun 01; 42():133-6. PubMed ID: 9327864
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dopaminergic regulation of striatal efferent pathways.
    Surmeier DJ, Kitai ST.
    Curr Opin Neurobiol; 1994 Dec 01; 4(6):915-9. PubMed ID: 7888777
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec 01; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

  • 18. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG, Kobierski LA, Konradi C, Hyman SE.
    Proc Natl Acad Sci U S A; 1994 Sep 27; 91(20):9631-5. PubMed ID: 7937819
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M, Mennicken F, Chritin M, Abrous DN, Feuerstein C, Le Moal M, Herman JP.
    Neuroscience; 1992 Sep 27; 46(3):729-38. PubMed ID: 1532053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.